# Probiotic Supplementation as Prophylactic for Group B β-hemolytic Streptococcus (GBS) Infection

> **NCT06231056** · NA · COMPLETED · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 250 (actual)

## Conditions studied

- Genitourinary; Infection, Complicating Pregnancy

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic iNatal®

## Key facts

- **NCT ID:** NCT06231056
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2024-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06231056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06231056, "Probiotic Supplementation as Prophylactic for Group B β-hemolytic Streptococcus (GBS) Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06231056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*